Edition:
United Kingdom

Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

138.55INR
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
Rs138.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
38,504
52-wk High
Rs269.10
52-wk Low
Rs115.25

Latest Key Developments (Source: Significant Developments)

Panacea Biotec Says India Resurgence Fund To Invest Up To $144 Mln In Co
Monday, 8 Apr 2019 

April 8 (Reuters) - PANACEA BIOTEC LTD : :INDIA RESURGENCE FUND ANNOUNCED INVESTMENT OF UP TO $144 MILLION IN CO.IINVESTMENT PROCEEDS WILL BE USED FOR, AMONG OTHERS, ONE-TIME SETTLEMENT WITH EXISTING LENDERS.INVESTMENT IS STRUCTURED VIA NCDS OF UP TO 8.64 BILLION RUPEES, SUBSCRIPTION AMOUNT OF 320 MILLION RUPEES FOR SHARE WARRANTS.SUBJECT TO EXERCISE OF WARRANTS, INDIARF, AFFILIATES, TO COLLECTIVELY OWN 10.4% STAKE CO.  Full Article

Panacea Biotec Approves One Time Settlement With Consortium Of Lenders Of Co
Tuesday, 26 Feb 2019 

Feb 26 (Reuters) - Panacea Biotec Ltd ::APPROVED ONE TIME SETTLEMENT WITH CONSORTIUM OF LENDERS OF CO.APPROVED DEMERGER OF REAL ESTATE BUSINESS OF COMPANY.APPROVED RAISING OF FUNDS THROUGH ISSUE OF NCDS AGGREGATING UPTO 8.64 BILLION RUPEES.APPROVED RAISING OF FUNDS VIA ISSUE OF WARRANTS BY ISSUING UP TO 7.1 MILLION WARRANTS OF 180 RUPEES EACH.APPROVED TRANSFER OF PHARMACEUTICAL FORMULATIONS BUSINESS OF CO TO UNIT OF CO AS A GOING CONCERN.  Full Article

India's Panacea Biotec Posts Sept-Qtr Loss
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Panacea Biotec Ltd ::SEPT QUARTER NET LOSS 974.9 MILLION RUPEES VERSUS LOSS OF 56.3 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 1.19 BILLION RUPEES VERSUS 1.53 BILLION RUPEES YEAR AGO.  Full Article

India's Panacea Biotec Gets EIR From U.S. FDA For Malpur Facility‍​
Friday, 9 Mar 2018 

March 9 (Reuters) - Panacea Biotec Ltd ::GETS EIR FROM U.S. FDA.GETS ESTABLISHMENT INSPECTION REPORT INDICATING FORMAL CLOSURE OF INSPECTION AT PHARMACEUTICAL FORMULATION FACILITY AT MALPUR.CO NOW ALLOWED TO CONTINUE SUPPLY OF ALL APPROVED DRUG PRODUCTS BY U.S. FDA INTO INTER-STATE COMMERCE.‍​.  Full Article

India's Panacea Biotec Dec Qtr Loss Narrows
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - India's Panacea Biotec Ltd ::DEC QUARTER NET LOSS 97.1 MILLION RUPEES VERSUS LOSS 254.2 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 1.52 BILLION RUPEES VERSUS 1.05 BILLION RUPEES YEAR AGO.  Full Article

Panacea Biotec Says U.S. FDA Accepts Co's Marketing Application For Generic Cancer Drug
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Panacea Biotec Ltd ::SAYS U.S. FDA ACCEPTS CO'S ANDA FOR PACLITAXEL PROTEIN BOUND PARTICLES.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter total income from operations 1.54 billion rupees versus 1.62 billion rupees year ago.  Full Article

India's Panacea Biotec Sept-qtr loss widens
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Panacea Biotec Ltd :Sept quarter net loss 56.3 million rupees versus loss 49.5 million rupees year ago.Sept quarter revenue from operations 1.53 billion rupees versus 1.41 billion rupees year ago.  Full Article

Panacea Biotec says ANDA of Prasugrel approved by U.S. FDA​
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Panacea Biotec Ltd :First-to-file ANDA of Prasugrel 5mg & 10mg tablets approved by U.S. FDA​.  Full Article

Panacea Biotec gets GMP compliance certificate from state service of Ukraine on Medicines and Drug Control‍​
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Panacea Biotec Ltd :Panacea Biotec - gets certificate of GMP compliance from state service of Ukraine on Medicines and Drug Control‍​.Panacea Biotec - certificate for manufacturing authorization for 22 medicinal products.  Full Article

No consensus analysis data available.